MARKET

APMD

APMD

Apnimed
NASDAQ
26.23
-0.57
-2.13%
After Hours: 26.69 +0.46 +1.75% 19:30 09/11 EDT
OPEN
27.07
PREV CLOSE
26.80
HIGH
27.72
LOW
26.19
VOLUME
207.78K
TURNOVER
--
52 WEEK HIGH
35.29
52 WEEK LOW
16.12
MARKET CAP
1.09B
P/E (TTM)
15.42
1D
5D
1M
3M
1Y
5Y
1D
Apnimed: What We Know Heading Into The Feb PDUFA
Seeking Alpha · 1d ago
Apnimed: Buy Rating Reiterated on Strong Oxnimbi OSA Profile and Unchanged $50 Price Target
TipRanks · 2d ago
Apnimed Swings To Q2 Profit, Eyes February 2027 FDA Decision On AD109 In Obstructive Sleep Apnea
NASDAQ · 2d ago
Apnimed, Inc. reports Q2 results
Seeking Alpha · 3d ago
Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M
Benzinga · 3d ago
*Apnimed 2Q Net $125.9M >APMD
Dow Jones · 3d ago
Press Release: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones · 3d ago
Press Release: Apnimed Reports Second Quarter -2-
Dow Jones · 3d ago
More
About APMD
Apnimed, Inc. is a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. The Company's clinical product candidate, AD109 (Oxnimbi), is an investigational, fixed-dose, anti-apneic neuromuscular modulator, combining a novel anti-muscarinic and a selective norepinephrine reuptake inhibitor (NRI) for the treatment of obstructive sleep apnea (OSA). Oxnimbi is designed to target the neuromuscular defect of OSA by improving upper airway muscle activity to help maintain airway patency and prevent airway collapse during sleep.

Webull offers Apnimed stock information, including NASDAQ: APMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APMD stock methods without spending real money on the virtual paper trading platform.